Important information concerning the analysis of Diabact UBT kits in UK and Ireland.

Currently all Diabact UBT kits delivered in UK has been analyzed by Glasgow Royal Infirmary Laboratory and this arrangement will continue until 30^th April 2013. Test results will be sent out to Doctors surgeries by normal postal services. Please note that test results cannot be received through MDE (neither web nor phone).

After the 1^st May a new analysis laboratory, situated in UK will perform the analysis in UK. Initially test results will only be sent out to Doctors surgeries by normal postal services. In the very near future test results will be retrievable through an on-line report service services.

To assure that the samples are sent to the relevant laboratory for analysis, always use the address label attached with the Diabact UBT Breath Test Kit for sending patient samples. Kibion will ensure that all samples are directed to the relevant laboratory.

The reason for the above changes in test arrangements is that Kibion AB, as the Market Authorization Holder for the pharmaceutical product Diabact UBT 50mg, has as of 4^th April 2013, with immediate effect, terminated the distribution contract of MDE Diagnostics UK Ltd, relating to the distribution of Diabact UBT in UK and Ireland.

Kibion will appoint a new distributor for UK and Ireland. In the meantime Kibion will handle any market issue through the Key Account Manager for UK and Ireland.

More information regarding Diabact UBT analysis, laboratory patient sample analysis and on line reporting services will be communicated via Kibion web site (kibion.com) and direct communication to customers.

For any urgent questions and enquiries, depending on the subject, please contact any of the below listed persons.

Petter Bäckgren
CEO
email hidden; JavaScript is required
Mobile: +46 70 555 69 97
Eva Kjaer
Manager Quality & Reg. Affairs
email hidden; JavaScript is required

Mobile: +46 72 726 06 36